The EU reportedly intends to levy a "significant" fine on Lundbeck (HLUYY.PK) for limiting...

|About: H. Lundbeck A/S ADR (HLUYY)|By:, SA News Editor

The EU reportedly intends to levy a "significant" fine on Lundbeck (HLUYY.PK) for limiting access to cheaper drugs through "pay for delay" deals in which brand name companies pay generic manufacturers not to enter the market with their products. The EU also plans to impose lighter penalties on Merck KGaA (MKGAF.PK) and seven smaller generic firms. The issue has aroused much controversy in the U.S., where a case has been heard by the Supreme Court.